Veterinary Implants Devices Market by Type (Orthopedic, Cardiovascular, Active Electronic, Drug Delivery), Application (Health Monitoring, Treatment Management), Animal (Companion, Livestock, Performance), End User (Hospitals) - Global Forecast to 2031

icon1
USD 0.98 BN
MARKET SIZE, 2031
icon2
CAGR 5.7%
(2026-2031)
icon3
390
REPORT PAGES
icon4
370
MARKET TABLES

OVERVIEW

veterinary-implants-devices-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The veterinary implant devices market is projected to reach USD 0.98 billion by 2031 from USD 0.74 billion in 2026, growing at a CAGR of 5.7% during the forecast period. The market is driven by the growing number of veterinary procedures requiring implantable solutions, particularly among companion animals. Increasing prevalence of orthopedic injuries, degenerative diseases, urinary disorders, and cardiovascular conditions is encouraging veterinarians and animal owners to pursue surgical and interventional treatments that incorporate implants. Beyond companion animals, demand from livestock, performance animals, wildlife, and research animals is broadening the market base. Livestock producers are increasingly using implantable identification and monitoring technologies to support herd management, while research institutions are adopting implantable telemetry and sensing devices for continuous physiological monitoring. At the same time, improvements in veterinary specialty services, greater availability of trained veterinary surgeons, and rising investment in animal healthcare infrastructure are increasing access to implant-based procedures across key markets.

KEY TAKEAWAYS

  • By Region
    By region, North America accounted for a 33.9% share of the global veterinary implant devices market in 2025.
  • By Implant Device
    By implant device, the monitoring, sensing, and diagnostic implants segment is expected to register a CAGR of 6.8% between 2026 and 2031.
  • By Animal Type
    By animal type, the companion animals segment held the largest share of the global veterinary implant devices market in 2025.
  • By Application
    By application, the activity, behavior, and performance enhancement segment is anticipated to exhibit a CAGR of 7.6% during the forecast period.
  • By End User
    By end user, the veterinary clinics and hospitals segment captured a 55.6% market share in 2025.
  • Competitive Landscape - CRO Key Players
    Merck & Co., Inc. (US), Elanco (US), Johnson & Johnson (DePuy Synthes) (US), Zoetis Inc (US), Virbac (France), B. Braun SE (Germany), Harvard Biosciences. Inc (Data Science International) (US), Securos Surgical (Cencora, Inc) (US), BioMedtrix, LLC (US), IMEX Veterinary, Inc (Movora) (US), KYON (Movora)(Switzerland), New Generation Devices (NGD)(US), Veterinary Orthopedic Implants (US), Arthrex, Inc (Arthrex Vet Systems) (US), and Infiniti Medical, LLC (US) were identified as some of the star players in the veterinary implant devices market, given their extensive global reach and comprehensive service portfolios.
  • Competitive Landscape - CRO Startups
    PH Orthcom (China), Veterinary Instrumentation (UK), Star Oddi (Iceland), Biotronik (Germany), Thema Biotel (Norway), SmaXtec Animal Care Gmbh (Austria), Auxilium MD (Teliatry, Inc.) (US), Biovetsensor (France), Norfolk Vet products (US), and Primetech Corporation (Japan). These companies strengthen their competitive positions by developing specialized veterinary implants, procedure-specific orthopedic and interventional devices, implantable monitoring and sensing technologies, and customized solutions addressing the needs of companion animals, livestock, research institutions, and other specialized veterinary applications.

The global veterinary implant devices market is driven by the increasing adoption of advanced veterinary procedures, rising animal healthcare expenditure, and growing use of implants for orthopedic, cardiovascular, urinary, reproductive, therapeutic, and monitoring applications. Expanding veterinary specialty care and livestock health management are further increasing implant utilization. Advances in 3D-printed, minimally invasive, patient-specific, and wireless implant technologies are improving treatment precision and monitoring capabilities, supporting broader adoption of veterinary implant devices.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

Major trends and disruptions shaped the veterinary implant devices market in 2025, driven by increasing adoption of patient-specific implants, minimally invasive procedures, advanced biomaterials, and implantable monitoring technologies. Expanding applications across companion-animal orthopedics, cardiovascular and interventional procedures, urinary and soft-tissue applications, livestock production, veterinary research, and wildlife monitoring are creating new opportunities, particularly in improved surgical outcomes, continuous animal monitoring, and species-specific treatment. Meanwhile, three-dimensional (3D) printing, artificial intelligence (AI)-enabled surgical planning, wireless telemetry, smart implants, implantable sensors, and digital animal-health platforms are improving implant selection, surgical precision, physiological monitoring, and clinical decision-making. Growing demand for personalized veterinary care, reduced procedure-related complications, continuous animal-health monitoring, and improved research efficiency is also accelerating the development of customized implants, connected monitoring systems, advanced cardiovascular devices, and specialized solutions for livestock, wildlife, and research applications. These developments are shifting the market toward new technologies, products, applications, integrated digital solutions, and specialized veterinary ecosystems.

veterinary-implants-devices-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Rising pet ownership and increasing humanization of companion animals
  • Increasing prevalence of diseases and disorders
RESTRAINTS
Impact
Level
  • High cost of veterinary implant procedures and devices
  • Shortage of trained veterinary surgeons specialized in implant-based procedures
OPPORTUNITIES
Impact
Level
  • Increasing development of 3D-printed, patient-specific veterinary implants and digital surgical planning
  • Expansion of veterinary implant applications in livestock and aquatic animals
CHALLENGES
Impact
Level
  • Clinical complications associated with veterinary implant devices
  • Regulatory and quality compliance complexity for veterinary implant devices

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising pet ownership and increasing humanization of companion animals

The growing adoption of pets and increasing humanization of companion animals are driving the demand for veterinary implant devices, particularly across orthopedic, therapeutic, cardiovascular, soft-tissue, and monitoring applications. As pet owners increasingly consider companion animals as family members, spending on advanced veterinary care is rising, including treatments for fractures, joint disorders, ligament injuries, cardiovascular conditions, and chronic diseases. Greater emphasis on improving animal longevity, mobility, quality of life, and recovery is encouraging the adoption of fracture fixation systems, joint replacements, TPLO/TTA implants, implantable drug-delivery systems, cardiac devices, and monitoring implants, supporting continued expansion of the companion animal veterinary implant market.

Restraint: High cost of veterinary implant procedures and devices

The high cost of veterinary implant devices and associated surgical procedures can limit their adoption, particularly for companion animals, where treatment expenses are often borne directly by pet owners. The total cost can include the implant, diagnostic imaging, anesthesia, surgery, hospitalization, and post-operative care, while advanced procedures may also require specialized equipment and trained veterinary surgeons. Limited pet insurance coverage and high out-of-pocket expenses can make advanced implant procedures less affordable, leading some owners to delay treatment or choose lower-cost alternatives, thereby constraining the adoption of high-value veterinary implant devices.

Opportunity: Increasing development of 3D-printed, patient-specific veterinary implants and digital surgical planning

The increasing development of 3D-printed, patient-specific veterinary implants and digital surgical planning is creating opportunities for manufacturers to provide customized solutions for complex orthopedic and skeletal procedures. 3D printing enables implants to be designed according to an animal’s individual anatomy, supporting improved fit and procedure-specific designs for fracture fixation, bone reconstruction, joint replacement, and other complex surgeries. Digital imaging, 3D anatomical modeling, virtual surgical planning, and computer-assisted procedures further enable veterinarians to evaluate anatomy and plan implant placement before surgery. The growing availability of advanced imaging and additive manufacturing technologies is expected to support the development of customized implants and expand the use of personalized veterinary implant solutions.

Challenge: Clinical complications associated with veterinary implant devices

The risk of clinical complications remains a key challenge in the adoption of veterinary implant devices, particularly across orthopedic, cardiovascular, urinary, and other invasive applications. Complications such as infection, inflammation, implant migration or loosening, tissue damage, fracture, rejection, and inadequate healing can occur depending on the implant type, surgical technique, animal condition, and post-operative care. These complications may require additional procedures, implant revision or removal, and extended treatment, increasing the overall cost and clinical burden. Differences in animal anatomy, physiology, activity levels, and healing responses further complicate the prediction of implant performance, requiring appropriate implant selection, surgical expertise, post-operative monitoring, and follow-up care.

VETERINARY IMPLANT DEVICES MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Enables controlled delivery of growth-promoting hormones through veterinary cattle implants, including the Synovex portfolio, across different stages of beef production Supports improved weight gain, feed efficiency, and production performance through sustained implant-based hormone delivery
company logo
Provides sustained-release veterinary implants, including Suprelorin, for controlled hormonal and reproductive management in dogs and ferrets Enables reversible and long-duration reproductive management while reducing the need for repeated treatments or surgical intervention
company logo
Develops veterinary orthopedic implant systems, including total hip replacement, knee, elbow, and fracture fixation systems, designed for companion-animal orthopedic procedures Improves joint reconstruction, skeletal stabilization, and mobility in dogs and other companion animals while supporting treatment of complex orthopedic conditions
company logo
Develops growth-promoting implant technologies, including Revalor implants, for controlled hormone delivery in beef cattle Improves cattle growth and feed efficiency while supporting production-performance management across different livestock production stages
company logo
Develops veterinary orthopedic implant systems, including plates, screws, fracture-fixation systems, and TPLO/TTA solutions for companion animals IImproves cattle growth and feed efficiency while supporting production-performance management across different livestock production stages

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The veterinary implant devices market forms an ecosystem comprising veterinary implant product manufacturers, animal health companies, veterinary hospitals and clinics, research and academic institutions, and regulatory bodies. Key manufacturers and animal health companies such as Zoetis Inc., BioMedtrix, DePuy Synthes, Securos Surgical, Virbac, and Merck provide orthopedic, therapeutic, reproductive, growth-promoting, identification, monitoring, and other veterinary implant solutions. End users include veterinary clinics and hospitals such as VCA and Ringpai Pet Hospital, as well as research and academic institutions such as the Indian Veterinary Research Institute and Iowa State University College of Veterinary Medicine. Regulatory stakeholders, including the US Food and Drug Administration (FDA), European Medicines Agency (EMA), Australian Pesticides and Veterinary Medicines Authority (APVMA), and Ministry of Agriculture and Rural Affairs of the People's Republic of China, establish requirements governing veterinary products and animal health applications. The ecosystem is further supported by veterinary professionals, livestock operations, pharmaceutical and biotechnology companies, and research organizations, driving the development and adoption of advanced implants focused on animal health, treatment outcomes, monitoring, recovery, and long-term care.

veterinary-implants-devices-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

veterinary-implants-devices-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Veterinary Implant Devices Market, By Implant Device

In 2025, orthopedic and skeletal implants held the largest share of the veterinary implant devices market. The segment benefits from the wide range of implant systems used to manage musculoskeletal conditions in companion animals, including fracture fixation plates, screws, pins, joint replacement systems, and TPLO/TTA implants. Growing adoption of specialized orthopedic procedures, improvements in implant design and fixation techniques, and increasing demand for durable, biocompatible implants are supporting the segment. The increasing availability of veterinary orthopedic specialists and advanced surgical facilities is further expanding the use of these devices.

Veterinary Implant Devices Market, By Application

In 2025, orthopedic and fracture repair accounted for the largest share of the veterinary implant devices market. The application covers a range of procedures performed to restore bone stability and mobility following traumatic fractures, cranial cruciate ligament injuries, joint damage, and other musculoskeletal disorders. Rising incidence of orthopedic conditions in companion animals, greater diagnosis of injuries through advanced imaging, and increasing acceptance of surgical intervention are driving procedure volumes. The growing use of minimally invasive and advanced fixation techniques is also supporting demand for implant-based fracture repair.

Veterinary Implant Devices Market, By End User

In 2025, veterinary clinics and hospitals captured the largest share of the veterinary implant devices market. These facilities account for a substantial proportion of implant procedures because they provide the diagnostic, surgical, anesthesia, imaging, and postoperative care required for implant placement. The expansion of specialty and referral hospitals, increasing availability of veterinary orthopedic and surgical specialists, and investment in advanced operating and diagnostic infrastructure are enabling clinics and hospitals to perform more complex implant-based procedures. Their role across multiple implant applications, including orthopedic, cardiovascular, urinary, and soft-tissue procedures, further supports their leading market position.

REGION

Asia Pacific to be fastest-growing region in global veterinary implant devices market during forecast period

During the forecast period, Asia Pacific is expected to register the highest CAGR in the veterinary implant devices market. The region's growth is mainly driven by rising pet ownership, increasing expenditure on animal healthcare, expansion of specialty veterinary hospitals, and growing adoption of advanced orthopedic and surgical procedures in countries such as China, Japan, India, Australia, and South Korea, particularly for fracture fixation, cranial cruciate ligament repair, TPLO, TTA, and joint replacement procedures. Rising pet healthcare expenditure and the expansion of specialty veterinary hospitals are increasing access to these procedures, while improvements in diagnostic imaging and surgical capabilities are enabling more complex implant-based interventions. In parallel, the region's substantial livestock population supports demand for production implants, reproductive implants, identification technologies, and intraruminal and physiological monitoring devices, particularly as commercial livestock operations adopt more data-driven animal-health and production-management practices. The combination of expanding companion-animal specialty care, large-scale livestock production, and improving veterinary infrastructure is expected to accelerate adoption of veterinary implant devices across the region.

veterinary-implants-devices-market Region

VETERINARY IMPLANT DEVICES MARKET: COMPANY EVALUATION MATRIX

Merck & Co., Inc. emerges as a prominent player in the veterinary implant devices market, supported by its broad animal health portfolio, established livestock presence, and expertise in implant-based production and animal identification technologies. Through Merck Animal Health, the company serves livestock and companion-animal markets, with veterinary implants primarily used in cattle production and animal identification and monitoring applications. Merck's position is supported by its revalor cattle implant portfolio. The company's strong position is further supported by its established global commercial infrastructure, extensive livestock customer base, and integration of animal health, production, identification, and monitoring technologies. Merck Animal Health's ability to provide products addressing cattle growth performance strengthens its product footprint across livestock applications. Its established relationships with veterinarians, livestock producers, and animal-health professionals, combined with continued investment in animal health technologies, support its market presence and provide opportunities for further expansion in the veterinary implant devices market. BioMedtrix (US) is a recognized player in the veterinary implant devices market, specializing in orthopedic implants for companion animals. Its portfolio includes hip replacement systems (BFX and CFX), TPLO bone plates, and I-Loc intramedullary fixation systems for treating orthopedic conditions and fractures. The TPLO Curve plate features a silver-based antimicrobial HyProtect coating designed to provide localized infection protection. Through continued product innovation and a specialized focus on companion-animal orthopedics, the company contributes to the advancement of veterinary implant solutions.

veterinary-implants-devices-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 0.71 BN
Market Size in 2026 (Value) USD 0.74 BN
Market Forecast in 2031 (Value) USD 0.98 BN
Growth Rate CAGR of 5.7% from 2026-2031
Years Considered 2024-2031
Base Year 2025
Forecast Period 2026-2031
Units Considered Value (USD Million/Billion), Volume (Thousand/Million Units)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Implant Device:
    • Orthopedic and Skeletal Implants
    • Cardiovascular and Interventional Implants
    • Active Electronic Implants
    • Urinary and Soft Tissue Implants
    • Therapeutic and Drug Delivery Implants
    • Monitoring
    • Sensing
    • and Diagnostic Implants
    • and Other Implant Devices
  • By Application:
    • Orthopedic and Fracture Repair
    • Cardiovascular and Interventional Treatment
    • Health and Wellness Monitoring
    • Activity
    • Behavior
    • and Performance Monitoring
    • Treatment
    • Drug Delivery
    • and Reproductive Management
    • Production Performance Enhancement
    • and Other Applications
  • By Animal Type:
    • Companion Animals
    • Performance and Sport Animals
    • Livestock
    • Wildlife
    • and Conservation Animals
    • Zoo Animals
    • Research Animals
    • and Other Animals
  • By End User:
    • Veterinary Clinics and Hospitals
    • Livestock Farms and Production Operations
    • Pharmaceutical and Biotechnology Companies and Contract Research Organizations
    • Veterinary Research Institutes and Academic Institutions
    • Wildlife and Conservation Organizations
    • and Other End Users
Regions Covered North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

WHAT IS IN IT FOR YOU: VETERINARY IMPLANT DEVICES MARKET REPORT CONTENT GUIDE

veterinary-implants-devices-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Product Analysis Compared key veterinary implant categories, including orthopedic and skeletal, cardiovascular and interventional, urinary and soft-tissue, active electronic, therapeutic/drug-delivery, and monitoring/sensing implants. Evaluated product types, implant materials, fixation technologies, species suitability, procedure applications, clinical requirements, implantation methods, technology maturity, and adoption trends across companion animals, livestock, research, and wildlife applications. Enabled identification of suitable implant technologies, product specifications, clinical requirements, and application benchmarks. Supported decisions related to product portfolio development, technology selection, implant design, product differentiation, and expansion into emerging veterinary applications.
Company Information Profiled major players including Merck & Co., Inc., Elanco, Johnson & Johnson (DePuy Synthes Vet), Zoetis, Virbac, B. Braun, Harvard Bioscience (Data Sciences International), Securos Surgical, BioMedtrix, IMEX Veterinary, KYON, New Generation Devices (NGD), Veterinary Orthopedic Implants, Arthrex Vet Systems, and Infiniti Medical. Provided insights into product portfolios, implant technologies, manufacturing capabilities, application focus, geographic presence, partnerships, acquisitions, R&D activities, and competitive positioning. Provided clarity on competitive positioning, product differentiation, manufacturing capabilities, application expertise, R&D strengths, geographic expansion, and strategic priorities. Supported evaluation of potential technology partners, suppliers, distributors, acquisition targets, and collaboration opportunities across veterinary implant applications.
Geographic Analysis Provided region-by-region analysis of veterinary implant adoption across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, including pet healthcare expenditure, veterinary infrastructure, specialty hospital development, livestock production, implant adoption trends, regulatory environment, clinical capabilities, and investment opportunities. Supported global strategy planning by identifying regional growth opportunities for veterinary implant devices. Helped evaluate market maturity, regulatory requirements, specialist availability, local manufacturing and distribution opportunities, and potential regions for capacity expansion, partnerships, and market entry.

RECENT DEVELOPMENTS

  • May 2026 : Zoetis received expanded US approval for Synovex one grower, extending its use to increase the rate of weight gain in growing beef steers and heifers in dry lots or on pasture with insufficient forage.
  • April 2026 : Arthrex Vet Systems highlighted the use of its OrthoLine distal femur osteotomy system, including plates and screws, to support surgical treatment of a dog with complex femoral fractures, demonstrating the application of its veterinary orthopedic implant portfolio in complex fracture repair.
  • July 2025 : Virbac received marketing authorization in Japan for Suprelorin (deslorelin acetate) implant, expanding availability of its reversible, minimally invasive reproductive-management implant for companion animals.

Table of Contents

checkmarkExclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
15
 
NOTE FOR 1.3.1 — EXCLUSIONS MUST STATE EXPLICITLY: (I) IDENTIFICATION, TRACEABILITY AND OWNERSHIP-AUTHENTICATION IMPLANTS (RFID/NFC TRANSPONDERS) ARE EXCLUDED AND COVERED IN THE LIVESTOCK IDENTIFICATION MARKET REPORT; (II) EXTERNAL AND BODY-WORN MONITORING DEVICES (SMART TAGS, COLLARS, EAR TAGS) ARE EXCLUDED AND COVERED IN THE LIVESTOCK MONITORING MARKET REPORT; (III) HUMAN-LABELLED DEVICES USED OFF-LABEL IN ANIMALS (DONATED PACEMAKERS, HUMAN CGM SENSORS) ARE DISCUSSED QUALITATIVELY BUT EXCLUDED FROM MARKET SIZING.
 
 
 
 
 
NOTE FOR 1.2.2 — INTRARUMINAL BOLUSES ARE INDWELLING RATHER THAN SURGICALLY IMPLANTED. THE MARKET DEFINITION INCLUDES “IMPLANTED OR LONG-TERM INDWELLING DEVICES” AND IS INCLUDED IN THE REPORT.
 
 
 
 
2
EXECUTIVE SUMMARY
 
 
 
 
3
PREMIUM INSIGHTS
 
 
 
 
4
MARKET OVERVIEW
Highlights the market structure, growth drivers, restraints, and near-term inflection points influencing performance.
 
 
 
 
 
4.1
INTRODUCTION
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
4.2.4
CHALLENGES
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
5
INDUSTRY TRENDS
Covers the key developments, trend analysis, and actionable insights to support strategic planning and positioning.
 
 
 
 
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
5.2.2
GDP TRENDS & FORECAST
 
 
 
 
5.2.3
TRENDS IN GLOBAL VETERINARY HEALTHCARE INDUSTRY
 
 
 
 
5.2.4
TRENDS IN GLOBAL VETERINARY MEDICAL DEVICES INDUSTRY
 
 
 
 
5.2.5
COMPANION ANIMAL OWNERSHIP AND LIVESTOCK POPULATION TRENDS
 
 
 
5.3
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
5.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.6
PRICING ANALYSIS
 
 
 
 
 
 
5.6.1
AVERAGE SELLING PRICE TREND, BY IMPLANT DEVICE TYPE, 2023–2025
 
 
 
 
5.6.2
AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025
 
 
 
5.7
TRADE ANALYSIS
 
 
 
 
 
 
5.7.1
IMPORT SCENARIO (HS CODE 9021)
 
 
 
 
5.7.2
EXPORT SCENARIO (HS CODE 9021)
 
 
 
 
5.7.3
LIMITATIONS OF HS CODE 9021 AS PROXY FOR VETERINARY IMPLANT TRADE
 
 
 
5.8
KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
5.10
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
5.11
CASE STUDY ANALYSIS
 
 
 
 
5.12
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
 
 
 
 
5.13
IMPACT OF US TARIFFS – GLOBAL VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
 
5.13.1
INTRODUCTION
 
 
 
 
5.13.2
KEY TARIFF RATES
 
 
 
 
5.13.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.13.4
IMPACT ON REGIONS
 
 
 
 
 
5.13.4.1
NORTH AMERICA
 
 
 
 
5.13.4.2
EUROPE
 
 
 
 
5.13.4.3
ASIA PACIFIC
 
 
 
5.13.5
IMPACT ON END USERS
 
 
 
NOTE FOR 5.7.3 — HS 9021 COVERS ORTHOPEDIC APPLIANCES AND ARTIFICIAL BODY PARTS FOR HUMAN USE; VETERINARY IMPLANTS HAVE NO DISTINCT CLASSIFICATION. THE CHAPTER IS RETAINED AS A DIRECTIONAL SUPPLY-CHAIN PROXY ONLY, AND THIS LIMITATION MUST BE STATED IN THE CHAPTER AND REPEATED IN 13.7.
 
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
 
 
 
 
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
6.1.1
BIOABSORBABLE AND RESORBABLE IMPLANT MATERIALS
 
 
 
 
6.1.2
PATIENT-SPECIFIC AND 3D-PRINTED IMPLANTS
 
 
 
 
6.1.3
WIRELESSLY POWERED AND BATTERY-FREE ACTIVE IMPLANTS
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
6.2.1
LONG-ACTING AND CONTROLLED-RELEASE DRUG DELIVERY PLATFORMS
 
 
 
 
6.2.2
ADVANCED IMPLANT COATINGS AND SURFACE MODIFICATION TECHNOLOGIES
 
 
 
6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
6.3.1
IMPLANTABLE BIOSENSING AND CONTINUOUS DIAGNOSTICS
 
 
 
 
6.3.2
WEARABLE AND REMOTE ANIMAL HEALTH MONITORING TECHNOLOGIES
 
 
 
6.4
PATENT ANALYSIS
 
 
 
 
 
6.5
FUTURE APPLICATIONS
 
 
 
 
6.6
IMPACT OF AI/GEN AI ON VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
 
 
6.6.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
6.6.2
BEST PRACTICES FOLLOWED BY COMPANIES IN VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
6.6.3
CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION IN VETERINARY IMPLANT DEVICES MARKET
 
 
 
 
6.6.4
INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
6.6.5
CLIENTS’ READINESS TO ADOPT AI/GEN AI-INTEGRATED VETERINARY IMPLANT DEVICES
 
 
 
6.7
HUMAN-LABELLED DEVICES ADOPTED OFF-LABEL IN VETERINARY PRACTICE (QUALITATIVE)
 
 
 
7
REGULATORY LANDSCAPE
 
 
 
 
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
7.1.3
REGULATION OF VETERINARY GROWTH-PROMOTANTS AND HORMONE IMPLANTS, BY REGION
 
 
 
 
7.1.4
RULES AND RESTRICTIONS APPLIED TO RACING AND COMPETITION ANIMALS
 
 
 
7.2
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
 
 
 
 
7.3
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
 
 
 
 
NOTE FOR 7.1.3 — HORMONAL GROWTH-PROMOTING IMPLANTS ARE BANNED IN THE EU AND PERMITTED IN THE US, CANADA, AUSTRALIA AND BRAZIL. THIS ASYMMETRY IS THE SINGLE LARGEST DRIVER OF REGIONAL VARIANCE IN THE LIVESTOCK SEGMENT AND MUST BE REFLECTED IN THE REGIONAL FORECASTS.
 
 
 
 
8
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
 
 
 
 
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
8.2
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
8.2.2
EVALUATION CRITERIA
 
 
 
8.3
ADOPTION BARRIERS AND INTERNAL CHALLENGES
 
 
 
 
8.4
UNMET NEEDS OF VARIOUS END USERS
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
 
8.6
WILLINGNESS TO PAY: PET OWNERS, LIVESTOCK PRODUCERS, AND INSTITUTIONAL BUYERS
 
 
 
9
VETERINARY IMPLANT DEVICES MARKET, BY IMPLANT DEVICE (MARKET SIZE & FORECAST TO 2031- IN VALUE, USD MILLION)
 
 
 
 
 
9.1
INTRODUCTION
 
 
 
 
9.2
ORTHOPEDIC AND SKELETAL IMPLANTS
 
 
 
 
 
9.2.1
FRACTURE FIXATION PLATES, SCREWS, AND PINS
 
 
 
 
9.2.2
JOINT REPLACEMENT SYSTEMS
 
 
 
 
9.2.3
TPLO AND TTA IMPLANTS
 
 
 
 
9.2.4
OTHER ORTHOPEDIC AND SKELETAL IMPLANTS
 
 
 
9.3
CARDIOVASCULAR AND INTERVENTIONAL IMPLANTS
 
 
 
 
 
9.3.1
OCCLUDERS AND CLOSURE DEVICES
 
 
 
 
9.3.2
STENTS (TRACHEAL, BRONCHIAL, URETHRAL, AND VASCULAR)
 
 
 
 
9.3.3
TRANSCATHETER VALVE REPAIR DEVICES
 
 
 
 
9.3.4
OTHER CARDIOVASCULAR AND INTERVENTIONAL IMPLANTS
 
 
 
9.4
ACTIVE ELECTRONIC IMPLANTS
 
 
 
 
 
9.4.1
NEUROSTIMULATION IMPLANTS
 
 
 
 
9.4.2
CARDIAC RHYTHM MANAGEMENT IMPLANTS
 
 
 
 
9.4.3
OTHER ACTIVE ELECTRONIC IMPLANTS
 
 
 
9.5
URINARY AND SOFT TISSUE IMPLANTS
 
 
 
 
 
9.5.1
SUBCUTANEOUS URETERAL BYPASS SYSTEMS
 
 
 
 
9.5.2
ARTIFICIAL URETHRAL SPHINCTER SYSTEMS
 
 
 
 
9.5.3
OTHER URINARY AND SOFT TISSUE IMPLANTS
 
 
 
9.6
THERAPEUTIC AND DRUG DELIVERY IMPLANTS
 
 
 
 
 
9.6.1
IMPLANTABLE DRUG DELIVERY DEVICES
 
 
 
 
9.6.2
REPRODUCTIVE AND FERTILITY MANAGEMENT IMPLANTS
 
 
 
 
9.6.3
GROWTH-PROMOTANT AND PRODUCTION PERFORMANCE IMPLANTS
 
 
 
 
9.6.4
PAIN MANAGEMENT IMPLANTS
 
 
 
 
9.6.5
OTHER THERAPEUTIC AND DRUG DELIVERY IMPLANTS
 
 
 
9.7
MONITORING, SENSING, AND DIAGNOSTIC IMPLANTS
 
 
 
 
 
9.7.1
TEMPERATURE MONITORING IMPLANTS
 
 
 
 
9.7.2
VITAL-SIGN MONITORING IMPLANTS
 
 
 
 
9.7.3
ACTIVITY AND MOTION SENSING IMPLANTS
 
 
 
 
9.7.4
IMPLANTABLE BIOSENSORS AND DIAGNOSTIC IMPLANTS
 
 
 
 
9.7.5
INTRARUMINAL BOLUSES (INDWELLING MONITORING DEVICES)
 
 
 
 
9.7.6
OTHER MONITORING AND SENSING IMPLANTS
 
 
 
9.8
OTHER IMPLANT DEVICES
 
 
 
 
9.9
GLOBAL VOLUME ANALYSIS, BY IMPLANT DEVICE, 2024–2031 (UNITS)
 
 
 
 
NOTE: OTHER ORTHOPEDIC AND SKELETAL IMPLANTS INCLUDE SPINAL IMPLANTS, EXTERNAL SKELETAL FIXATION COMPONENTS, AND MAXILLOFACIAL IMPLANTS.
 
 
 
 
 
OTHER CARDIOVASCULAR AND INTERVENTIONAL IMPLANTS INCLUDE EMBOLIZATION COILS, PERMANENT EMBOLIZATION IMPLANTS/MATERIALS, CARDIOVASCULAR PATCHES, VASCULAR GRAFTS, AND SPECIALIZED VASCULAR RECONSTRUCTION IMPLANTS.
 
 
 
 
 
OTHER ACTIVE ELECTRONIC IMPLANTS INCLUDE IMPLANTABLE ELECTRICAL STIMULATION DEVICES AND EXPERIMENTAL/EMERGING VETERINARY BIOELECTRONIC IMPLANTS.
 
 
 
 
Request for detailed methodology, assumptions & how numbers were triangulated.
Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Veterinary Implants Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Veterinary Implants Devices Market

DMCA.com Protection Status
popup img